Kangtai Bio revises convertible bond conversion price downward
Shenzhen Kangtai Biological Products has announced a downward revision of the conversion price for its "Kangtai Convertible 2" bonds (SZSE:123119), a decision made and approved during a series of board and shareholder meetings held throughout February and March 2025. Effective March 27, 2025, the new conversion price has been set at CNY 15.82 per share, reduced from the previous CNY 19.81 per share. This decision, based on the company's Articles of Association, became necessary when the company's stock price fell below 85% of the current conversion price for at least 15 out of 30 consecutive trading days.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Shenzhen Kangtai Biological Products publishes news
Free account required • Unsubscribe anytime